January 16, 2021

The Niche

Trusted stem cell blog & resources

CIRM

4 min read

Approval of Prop 14 California last month to renew CIRM was one of the biggest state election developments of 2020. Yet it didn’t get much news coverage somehow. The exception is David Jensen over at California Stem Cell Report, who has been a great source of information about the various news surrounding Prop 14 and CIRM so check that out. CIRM is having a public meeting today about its future. You are welcome to participate. As Jensen notes, CIRM has a lot of information …Read More

3 min read

There have been many other interesting scientific and specifically regenerative medicine developments and papers this past week including with CIRM and exciting CIRM funding to UC Davis so read on, but first a somewhat random question: are you more of a cat person or dog person? I’d say I’m both. But our big dog is not a fan of cats so I have to get my random cat time in on walks if I happen to run into a cat. I crossed paths with …Read More

2 min read

The State of California is considering re-funding its stem cell agency, CIRM, to the tune of more than $5 billion dollars, but the issue has generated surprisingly little media attention. The main coverage has been by David Jensen over at California Stem Cell Report. Prop 14 polling data non-existent in public domain To my knowledge, there are also no poll results in the public domain about how California voters feel about Proposition 14, which is the measure that would give the stem cell agency …Read More

2 min read

Back at the beginning of the year I surveyed you readers here on The Niche about the future of CIRM and whether California voters would approve more funding for it in November. That funding effort is now on the ballot as Proposition 14. A month earlier late in 2019 in my yearly 20 predictions for the stem cell and regenerative medicine field I had prognosticated that we California voters would narrowly approve more funding for the California Stem Cell Agency. You can see that …Read More

2 min read

Should California’s Stem Cell Agency, more widely known as CIRM, get another round of funding from us California voters? I believe the answer is yes and I endorse Proposition 14, which would provide the funding for CIRM to translate dozens of clinical trials into some proven new stem cell-based treatments in the coming decade. However, my just saying that as a stem cell scientist doesn’t necessarily have the same resonance as other approaches like a funny new video starring a stem cell who pitches …Read More

4 min read

Why is former Texas Governor/Trump Energy Secretary Rick Perry plugging unproven stem cells from a clinic firm called Celltex for COVID-19 prevention on Fox News? Perry follows in Giuliani’s footsteps? And more generally, what is it with conservative politicians promoting unproven therapies for COVID-19 and in particular stem cells for the novel coronavirus disease? First, we had Rudy Giuliani plugging what he called “stem cells” for COVID-19 on his webcast. This actually turned out to be natural killer (NK) cells, which are not stem …Read More

3 min read

There is always plenty of complicated, mixed-bag news on the stem cell and regenerative medicine front so it’s great to highlight when there’s some good news out there. Today’s post includes several such upbeat items. At the bottom I’ve included a list of some recent interesting publications as well. Good news on vision front: jCyte Therapy Deal with Santen Pharmaceutical. David Jensen over at California Stem Cell Report reported on this blockbuster deal for a quarter of a billion dollars. Jensen wrote: “The California …Read More

2 min read

The California Stem Cell Agency, better known by the acronym CIRM, has done a vast amount of good over the past decade and a half, and today it needs your help for the future. CIRM, which stands for the “California Institute for Regenerative Medicine”, has funded a huge array of stem cell and other research projects. The CIRM of today and the future primarily supports clinical trial efforts aimed at finding new treatments and even cures for many serious illnesses. These efforts now even …Read More

3 min read

It’s notable how the FDA now considers gene-editing a kind of regenerative medicine. This means that various gene therapy products in development technically qualify as regenerative therapies. Ever since the agency began its rapidly growing regenerative medicine advanced therapy (RMAT) designation program, we’ve seen an increasing number of gene therapy biotechs and products qualify as RMATs. As a result, the RMAT-qualified gene therapies get to go into a speedier lane of FDA oversight. Today’s post is a mix of recommended reads in the regenerative …Read More

2 min read

I recently started 2 polls on the future of CIRM. The polls are focused on the effort led by Robert Klein to get more funding from the State of California for the stem cell agency. They asked readers about whether Californians will refund CIRM and whether Californians should refund CIRM. Basically, the polls are asking what readers think will happen and what they want to happen in terms of CIRM potentially getting $5 billion more in funding. The results of these non-scientific polls are …Read More